Evidence map›Paper›PMID 20601885›Full record

ReviewCurrent opinion in pediatrics2010

Hypercalcemia in children and adolescents.

Steven A Lietman, Emily L Germain-Lee, Michael A Levine

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in pediatrics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 131 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Genetic causes of neonatal and infantile hypercalcaemia.Pediatric nephrology (Berlin, Germany) · 2022
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. A toddler with severe hypercalcemia and pyelonephritis: Answers.Pediatric nephrology (Berlin, Germany) · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Steven A LietmanOrthopaedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA. lietmas@ccf.org
Emily L Germain-Lee
Michael A Levine
Cleveland Clinic · USKennedy Krieger Institute · USUniversity of Pennsylvania · US

Funding

Molecular Mechanisms in Bone ResorptionR01DE018237 · NIDCR · CLEVELAND CLINIC LERNER COM-CWRU · PI LIETMAN, STEVEN A · 2008 to 2012
$1.7M
CLONING OF THE PSEUDOHYPOPARATHYROIDISM TYPE 1B GENER01DK056178 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI LEVINE, MICHAEL ALAN · 1999 to 2003
$1.6M
THE NUCLEOTIDE REGULATORY UNIT OF ADENYLATE CYCLASER01DK034281 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI LEVINE, MICHAEL A · 1986 to 2000
$321k
NIDCR NIH HHS DE-18237NIDCR NIH HHS R01 DE018237NIDDK NIH HHS DK-34281NIDDK NIH HHS DK-56178NIDDK NIH HHS R01 DK056178
6 · The paper itself

Abstract

purpose of reviewIn this review, we define hypercalcemia levels, common causes for hypercalcemia in children, and treatment in order to aid the practicing pediatrician. RECENT

findingsOne rare cause of hypercalcemia in the child is familial hypocalciuric hypercalcemia (also termed familial benign hypercalcemia). Mutations that inactivate the Ca-sensing receptor gene FHH have been described as an autosomal dominant disorder, but recently milder mutations in the CASR have been shown to cause hypercalcemia when homozygous. SUMMARY: Normal serum levels of calcium are maintained through the interplay of parathyroid, renal, and skeletal factors. In this review, we have distinguished the neonate and infant from the older child and adolescent because the causes and clinical features of hypercalcemia can differ in these two age groups. However, the initial approach to the medical treatment of severe or symptomatic hypercalcemia is to increase the urinary excretion of calcium in both groups. In most cases, hypercalcemia is due to osteoclastic bone resorption, and agents that inhibit or destroy osteoclasts are, therefore, effective treatments. Parathyroid surgery, the conventional treatment for adults with symptomatic primary hyperparathyroidism, is recommended for all children with primary hyperparathyroidism.

Indexed as

Genetic Predisposition to DiseaseHypercalcemiaAdolescentBone Density Conservation AgentsCalcitoninCalciumCalcium SignalingChildHumansMutationParathyroidectomyPrognosisReceptors, Calcium-SensingBone Density Conservation AgentsCalcitoninCalciumCASR protein, humanReceptors, Calcium-Sensing

Identifiers

PMID20601885
PMCPMC2967024
OpenAlexW2059252952

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.